Latest Insider Transactions at Moelis & CO (MC)
This section provides a real-time view of insider transactions for Moelis & CO (MC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moelis & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moelis & Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 07
2024
|
Christopher Callesano Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
885
-100.0%
|
$70,800
$80.0 P/Share
|
|
Oct 24
2024
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
391
-0.2%
|
$26,588
$68.24 P/Share
|
|
Oct 24
2024
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
890
+0.45%
|
-
|
|
Sep 26
2024
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.83%
|
-
|
|
Sep 26
2024
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.81%
|
-
|
|
Sep 26
2024
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
21
+0.85%
|
-
|
|
Sep 26
2024
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.83%
|
-
|
|
Sep 26
2024
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.81%
|
-
|
|
Sep 26
2024
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
21
+0.85%
|
-
|
|
Sep 26
2024
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
2
+0.82%
|
-
|
|
Sep 26
2024
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
17
+0.82%
|
-
|
|
Sep 26
2024
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.84%
|
-
|
|
Sep 24
2024
|
Louise Mirrer |
BUY
Grant, award, or other acquisition
|
Direct |
1,206
+50.0%
|
-
|
|
Jul 31
2024
|
Kenneth Shropshire |
SELL
Open market or private sale
|
Direct |
495
-5.02%
|
$34,155
$69.29 P/Share
|
|
Jul 31
2024
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
6,494
-100.0%
|
$448,086
$69.16 P/Share
|
|
Jul 30
2024
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
93,506
-93.51%
|
$6,358,408
$68.87 P/Share
|
|
Jul 30
2024
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
5,308
-98.41%
|
$360,944
$68.87 P/Share
|
|
Jul 30
2024
|
Ciafone Katherine Pilcher Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,666
-100.0%
|
$249,288
$68.88 P/Share
|
|
Jul 25
2024
|
Kenneth Moelis Chairman, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
55
+1.01%
|
-
|
|
Jul 25
2024
|
Kenneth Moelis Chairman, CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
100,000
+50.0%
|
-
|
|
Jul 25
2024
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
373
-0.19%
|
$23,126
$62.79 P/Share
|
|
Jul 25
2024
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
849
+0.43%
|
-
|
|
Jul 25
2024
|
Joseph Simon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,723
-100.0%
|
$430,272
$64.0 P/Share
|
|
Jul 25
2024
|
Joseph Simon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,723
+50.0%
|
-
|
|
Jul 01
2024
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
1,061
+50.0%
|
-
|
|
Jul 01
2024
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
1,938
+50.0%
|
-
|
|
Jul 01
2024
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
1,061
+50.0%
|
-
|
|
Jul 01
2024
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
1,938
+50.0%
|
-
|
|
Jul 01
2024
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
239
+50.0%
|
-
|
|
Jul 01
2024
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
2,030
+50.0%
|
-
|
|
Jun 20
2024
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
0
|
-
|
|
Jun 20
2024
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
28
+1.08%
|
-
|
|
Jun 20
2024
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
26
+1.0%
|
-
|
|
Jun 20
2024
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
3
+0.89%
|
-
|
|
Jun 20
2024
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
26
+1.05%
|
-
|
|
Jun 20
2024
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.99%
|
-
|
|
Jun 20
2024
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
3
+0.89%
|
-
|
|
Jun 20
2024
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
26
+1.05%
|
-
|
|
Jun 20
2024
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
13
+1.08%
|
-
|
|
May 13
2024
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Open market or private sale
|
Direct |
44,980
-100.0%
|
$2,428,920
$54.92 P/Share
|
|
May 10
2024
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
37,102
-87.42%
|
$2,003,508
$54.11 P/Share
|
|
May 09
2024
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
40,000
-48.52%
|
$2,120,000
$53.98 P/Share
|
|
Apr 25
2024
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
310
-0.16%
|
$16,430
$53.99 P/Share
|
|
Apr 25
2024
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
705
+0.36%
|
-
|
|
Mar 28
2024
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.66%
|
-
|
|
Mar 28
2024
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
26
+1.02%
|
-
|
|
Mar 28
2024
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.96%
|
-
|
|
Mar 28
2024
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.9%
|
-
|
|
Mar 28
2024
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
25
+1.02%
|
-
|
|
Mar 28
2024
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.97%
|
-
|